title: An expert's opinion on what lies ahead in the field of alternative drug delivery.
abstract: Tarun Goswami speaks to Hannah Makin, Commissioning Editor: Tarun Goswami obtained his BS (Pharmacy) in 2003 from Delhi University (India) and his PhD in Pharmaceutical Sciences in 2008 from the University of the Pacific (CA, USA). He currently works at Amneal Pharmaceuticals as a Formulation Scientist in the Transdermal Drug Delivery Group. Having published multiple abstracts and articles in the area of transdermal and oral mucosal drug delivery, his current interests include the development of drug products that are administered via alternate routes such as through the skin and oral mucosa.
authors.affiliation: Amneal Pharmaceuticals Transdermal drug delivery group 1 New England Ave Piscataway, NJ 08854 USA.
authors.forename: Tarun
authors.initials: T
authors.lastname: Goswami
mesh_terms: D000279:Administration, Cutaneous; D058956:Administration, Mucosal; D016503:Drug Delivery Systems / Q000639:trends*; D006801:Humans; D004364:Pharmaceutical Preparations; D012869:Skin Absorption
chemical_list: D004364:Pharmaceutical Preparations
keywords: sublingual microneedles; transdermal